Welcome to our dedicated page for FOXO Technologies news (Ticker: $FOXO), a resource for investors and traders seeking the latest updates and insights on FOXO Technologies stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect FOXO Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of FOXO Technologies's position in the market.
Rhea-AI Summary
FOXO Technologies Inc. received a Notice of Non-Compliance from NYSE for failing to file its Annual Report on Form 10-K by the due date. Despite challenges, the company is committed to regaining compliance, improving financial systems, and advancing transformative transactions to drive shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.1%
Tags
-
Rhea-AI Summary
FOXO Technologies Inc. announces a proposed merger with M2i Global, Inc. to focus on securing the nation's supply of critical materials and resources. The merger aims to develop a global value supply chain for critical minerals for the U.S. government and free trade partners, as well as create a strategic mineral reserve in partnership with the U.S. Federal Government. The collaboration brings together extensive experience, knowledge, and resources to drive value for shareholders and enhance operational efficiency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.66%
Tags
-
Rhea-AI Summary
FOXO Technologies Inc. appoints Francis Colt deWolf to its Board of Directors, bringing over 20 years of experience in the financial services sector. The Company also received a notice of noncompliance from NYSE Regulation regarding its audit committee composition.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.75%
Tags
Rhea-AI Summary
FOXO Technologies Inc. (NYSE American: FOXO) has announced the formalization of its collaboration with KR8.ai Inc. and the exclusive license to KR8's AI-based software to support the development and commercial launch of its new health and wellness offering - the VITHAR™ AI Health Coach. The company aims to provide personalized health and wellness recommendations by leveraging epigenetic data, genetic insight, and growing patent estate with AI-driven analytic software and proprietary algorithms. The goal is to capture a meaningful share of the Health and Fitness App Market, which is projected to reach $35.7 billion by 2030, through a cost-effective go-to-market strategy. The new app will require users to send a saliva or blood sample, and the technology will combine this information with user health stats, as well as peer-reviewed clinical studies and other verified health resources to provide customized AI-driven health recommendations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.49%
Tags
-
Rhea-AI Summary
FOXO Technologies Inc. (Ticker: FOXO) received a notice of noncompliance from NYSE Regulation due to the failure to timely file the Company’s Form 10-Q for the period ended September 30, 2023. The Company is committed to regaining compliance with the NYSE American’s continued listing requirements and has taken steps to enhance its financial infrastructure and ensure the highest standards of corporate governance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5%
Tags
-
News
Rhea-AI Summary
FOXO Technologies Inc. (NYSE American: FOXO) expects a reduction in losses of over $10 million for the third quarter of 2023 compared to the prior quarter. The company provided a business update on the planned commercial rollout of its new direct-to-consumer (DTC) app, the VITHAR™ AI Health Coach, and anticipates reporting financial results for the three and nine months ended September 30, 2023. The reduction in losses includes cash operational cost reductions in excess of $2.1 million over the second quarter of 2023. The company also plans to leverage social media influencers to enhance the commercial launch of the VITHAR AI Health Coach and expects annualized cost savings in excess of 52% for 2023, aiming to maintain a lean operating infrastructure to drive profitability following the commercial launch.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.82%
Tags
Rhea-AI Summary
FOXO Technologies Inc. (NYSE American: FOXO) received a notice from NYSE Regulation stating that the Company is not in compliance with the continued listing standards of the NYSE American due to the delayed filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023. The Company has a six-month initial cure period to file the Form 10-Q with the SEC, with the possibility of an additional six-month cure period if needed.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.72%
Tags
-
Rhea-AI Summary
FOXO Technologies Inc. (NYSE American: FOXO) announces a webinar to unveil its new direct-to-consumer app, the VITHAR™ AI Health Coach, designed to combine health and epigenetic data for actionable insights and coaching.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.04%
Tags
-
Rhea-AI Summary
FOXO Technologies Inc. (NYSE American: FOXO) announced a webinar on November 10, 2023, to introduce its new direct-to-consumer (DTC) app, the VITHAR™ AI Health Coach, which will leverage epigenetic data and algorithms to provide personalized health insights and coaching. The app aims to improve user's overall health and longevity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.87%
Tags
Rhea-AI Summary
FOXO Technologies Inc. (NYSE American: FOXO) is set to resume trading after a 1-for-10 reverse stock split to comply with NYSE American Company Guide. The company plans to drive commercialization through a new direct-to-consumer offering in partnership with KR8.ai.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.53%
Tags
FOXO Technologies Inc.
NYSE:FOXO
FOXO Rankings
FOXO Stock Data
2.46M
4.46M
35.97%
4.16%
4.06%
Software Publishers
Information
United States of America
MINNEAPOLIS
About FOXO
formerly yousurance and life epigenetics. foxo bioscience is transforming the global longevity insurance industry with a next-generation underwriting protocol and consumer engagement platform based on epigenetic technology and insights. we also offer leading supervised machine learning and artificial intelligence technologies to identify epigenetic biomarkers that measure current states of health and aging.